GREAT POINT PARTNERS LLC (Ortav Yehudai, Mr. David Kroin, Dr. Jeffrey R. Jay)

13F Portfolio Filings

Latest 13F report
Q1 2024 - May 15, 2024
Value $
$642 M
Notable people
Ortav Yehudai, Mr. David Kroin, Dr. Jeffrey R. Jay
Signature - Title
Dr. Jeffrey R. Jay, M.D. - Senior Managing Member
Location
165 Mason Street, 3 Rd Floor, Greenwich, Connecticut
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Date Filed
Q1 2024 35 $642 M +$222 M -$294 M -$71.6 M NGNE, ALPN, URGN, ABVX, EOLS 13F-HR 5/15/2024, 04:24 PM
Q4 2023 34 $587 M +$114 M -$189 M -$74.9 M ALPN, CYTK, URGN, PLRX, RARE 13F-HR 2/14/2024, 04:07 PM
Q3 2023 39 $532 M +$165 M -$92.4 M +$72.8 M URGN, ALPN, PLRX, PCVX, RARE 13F-HR 11/14/2023, 04:16 PM
Q2 2023 36 $499 M +$135 M -$147 M -$11.9 M ALPN, RARE, PCVX, PLRX, RAPT 13F-HR 8/14/2023, 04:17 PM
Q1 2023 42 $506 M +$181 M -$150 M +$30.4 M PLRX, XENE, ALPN, RARE, RAPT 13F-HR 5/15/2023, 04:09 PM
Q4 2022 40 $484 M +$219 M -$127 M +$91.4 M PCVX, XENE, RAPT, ALPN, PLRX 13F-HR 2/14/2023, 04:02 PM
Q3 2022 40 $406 M +$146 M -$166 M -$20.8 M XENE, JAZZ, PNT, ALPN, TVTX 13F-HR 11/14/2022, 04:24 PM
Q2 2022 32 $377 M +$128 M -$122 M +$5.9 M XENE, JAZZ, CYTK, TVTX, PCVX 13F-HR 8/15/2022, 04:25 PM
Q1 2022 29 $413 M +$137 M -$159 M -$21.5 M EXEL, XENE, TVTX, BCYC, JAZZ 13F-HR 5/16/2022, 04:24 PM
Q4 2021 35 $447 M +$171 M -$151 M +$20 M ARNA, EXEL, XENE, TVTX, ANAB 13F-HR 2/14/2022, 11:22 AM
Q3 2021 35 $423 M +$155 M -$173 M -$17.9 M EXEL, ARNA, KDMN, BCAB, RCKT 13F-HR 11/15/2021, 04:36 PM
Q2 2021 28 $447 M +$140 M -$146 M -$6.87 M MGNX, RCKT, ARNA, UTHR, PODD 13F-HR 8/16/2021, 04:33 PM
Q1 2021 28 $484 M +$165 M -$241 M -$75.9 M MGNX, RCKT, IOVA, SAGE, XENT 13F-HR 5/17/2021, 04:05 PM
Q4 2020 31 $607 M +$172 M -$884 M -$711 M GWPH, IOVA, SAGE, ACAD, RCKT 13F-HR 2/16/2021, 04:17 PM
Q3 2020 33 $1.11 B +$174 M -$336 M -$162 M IOVA, SAGE, ACAD, ARNA, ZYME 13F-HR 11/16/2020, 04:41 PM
Q2 2020 35 $1.24 B +$476 M -$244 M +$232 M CNST, IOVA, ZYME, ACAD, SAGE 13F-HR 8/14/2020, 04:55 PM
Q1 2020 32 $886 M +$248 M -$330 M -$82.1 M ACAD, ZYME, PTCT, IOVA, CNST 13F-HR 5/15/2020, 04:04 PM
Q4 2019 34 $1.04 B +$386 M -$541 M -$156 M IOVA, ZYME, PTCT, NXTC, TGTX 13F-HR 2/14/2020, 04:17 PM
Q3 2019 34 $945 M +$340 M -$75.4 M +$265 M IOVA, ZGNX, ACAD, BOLD, PTCT 13F-HR 11/15/2019, 02:01 PM
Q2 2019 25 $824 M +$236 M -$356 M -$120 M IOVA, PTCT, ZGNX, BOLD, KURA 13F-HR 8/14/2019, 04:05 PM
Q1 2019 31 $903 M +$181 M -$176 M +$5.17 M PTCT, ZGNX, GBT, BOLD, ACAD 13F-HR 5/14/2019, 04:05 PM
Q4 2018 34 $720 M +$350 M -$124 M +$227 M BCRX, IOVA, GBT, XLRN, ACAD 13F-HR 2/14/2019, 09:01 PM
Q3 2018 29 $637 M +$180 M -$208 M -$27.7 M BCRX, XLRN, ZFGN, IOVA, UTHR 13F-HR 11/14/2018, 04:00 PM
Q2 2018 31 $633 M +$206 M -$234 M -$27.5 M PTCT, KURA, IOVA, BCRX, ONCE 13F-HR 8/14/2018, 04:00 PM
Q1 2018 30 $640 M +$213 M -$183 M +$29.9 M IOVA, ARNA, KURA, PTCT, ZGNX 13F-HR 5/14/2018, 04:00 PM
Q4 2017 37 $574 M +$222 M -$116 M +$107 M ZGNX, ARNA, KURA, SAGE, GBT 13F-HR 2/14/2018, 04:10 PM
Q3 2017 31 $405 M +$77.4 M -$290 M -$212 M ZGNX, ARNA, CNCE, NBIX, FOMX 13F-HR 11/14/2017, 04:02 PM
Q2 2017 32 $520 M +$154 M -$106 M +$47.1 M ARNA, ADMS, VNDA, ZGNX, PTCT 13F-HR 8/14/2017, 04:12 PM
Q1 2017 32 $457 M +$158 M -$176 M -$18.1 M ADMS, CNCE, SGYPQ, VNDA, RIGL 13F-HR 5/15/2017, 04:00 PM
Q4 2016 31 $454 M +$129 M -$45.9 M +$83.2 M ADMS, FOMX, VNDA, SGYPQ, ZGNX 13F-HR 2/14/2017, 04:06 PM
Q3 2016 30 $383 M +$108 M -$133 M -$25.2 M VNDA, ADMS, SGYPQ, ZGNX, FOMX 13F-HR 11/14/2016, 05:31 PM
Q2 2016 37 $341 M +$127 M -$66.9 M +$60.2 M ADMS, VNDA, SGYPQ, EXEL, DERM 13F-HR 8/15/2016, 04:08 PM
Q1 2016 30 $262 M +$95.3 M -$2.81 M +$92.5 M ADMS, FPRX, VNDA, ZGNX, TTPHXXXX 13F-HR 5/16/2016, 03:02 PM
Q4 2015 21 $228 M +$37 M -$78.8 M -$41.8 M ADMS, FPRX, ZGNX, VNDA, TTPHXXXX 13F-HR 2/16/2016, 01:21 PM
Q3 2015 32 $232 M +$89.2 M -$29.8 M +$59.4 M VNDA, FPRX, CNXR, ADMS, ZGNX 13F-HR 11/16/2015, 10:58 AM
Q2 2015 31 $253 M +$103 M -$82.1 M +$21.2 M CNXR, ADMS, VNDA, FPRX, SGYPQ 13F-HR 8/14/2015, 01:11 PM
Q1 2015 30 $221 M +$76.1 M -$85.6 M -$9.48 M CNXR, HPTX, VNDA, OFIX, ADMS 13F-HR 5/15/2015, 11:49 AM
Q4 2014 27 $207 M +$85.5 M -$111 M -$25 M CNXR, HPTX, ALIM, OCRX, DSCI 13F-HR 2/17/2015, 09:19 AM
Q3 2014 34 $222 M +$82.1 M -$65.7 M +$16.4 M HPTX, NBIX, INFI, ALIM, OPHT 13F-HR 11/14/2014, 10:26 AM
Q2 2014 36 $219 M +$92 M -$42 M +$50 M NBIX, HPTX, DSCI, THOR, INFI 13F-HR 8/14/2014, 04:17 PM
Q1 2014 33 $180 M +$82.6 M -$54.4 M +$28.2 M FURX, HPTX, PTIE, ALIM, DSCI 13F-HR 5/15/2014, 04:30 PM
Q4 2013 26 $136 M $0 $0 HPTX, PTIE, FURX, SSH, AMBI 13F-HR 2/14/2014, 06:17 AM